This company seems to have been delisted
Reason: Merged with Commure
Last recorded trade on: December 4, 2024
Source: https://www.globenewswire.com/news-release/2024/10/02/2956933/0/en/Commure-Completes-Merger-with-Augmedix.html
Reason: Merged with Commure
Last recorded trade on: December 4, 2024
Source: https://www.globenewswire.com/news-release/2024/10/02/2956933/0/en/Commure-Completes-Merger-with-Augmedix.html
Augmedix
AUGX
$3.09
Share price
0.00%
Change (1 day)
-44.12%
Change (1 year)
Categories
Revenue for Augmedix (AUGX)
Revenue in 2024 (TTM): S$69.53 Million
According to Augmedix's latest financial reports the company's current revenue (TTM 
) is S$67.86 Million. In 2023 the company made a revenue of S$59.23 Million an increase over the revenue in the year 2022 that were of S$41.46 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Augmedix from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | S$69.53 M | 17.37% |
| 2023 | S$59.23 M | 42.85% |
| 2022 | S$41.46 M | 38.39% |
| 2021 | S$29.96 M | 37.42% |
| 2020 | S$21.8 M |